. La-moyenne-du-rapport-calciurie, 28 mmol/mmol [0,04-1,48? pour une norme aux environ de 0,4-0,6 mmol/mmol. On note des calciuries très basses (calciurie

. Il-existe-un-lien-significatif-entre-igf1 and . Klotho, Plus les valeurs d'IgF1 augmentent et plus Klotho se majorent également ([R² = 0, pp.22-40

R. Hankard, V. Colomb, H. Piloquet, A. Bocquet, J. Bresson et al., Malnutrition screening in clinical practice]. Arch Pediatr Organe Off Soc Francaise Pediatr, oct, vol.19, issue.10, pp.1110-1117, 2012.

E. Masson, Le syndrome de renutrition inappropriée : la clé du traitement est la prévention

J. Bacchetta and A. , Physiologie : calcium et phosphate. (Pathologie phosphocalcique et osseuse de l'enfant)

J. Bacchetta and A. , Dosage des principaux paramètres du métabolisme phosphocalcique, Pathologie phosphocalcique et osseuse de l'enfant

J. Bacchetta and A. , Vitamine D : effets squelettiques et généraux, Pathologie phosphocalcique et osseuse de l'enfant

M. Vidailhet, E. Mallet, A. Bocquet, J. Bresson, A. Briend et al., Vitamin D: still a topical matter in children and adolescents. A position paper by the Committee on Nutrition of the French Society of Paediatrics. Arch Pediatr Organe Off Soc Francaise Pediatr, mars, vol.19, issue.3, pp.316-344, 2012.

J. Bacchetta, B. Ranchin, L. Dubourg, and P. Cochat, Vitamin D revisited: a cornerstone of health?]. Arch Pediatr Organe Off Soc Francaise Pediatr, déc, vol.17, issue.12, pp.1687-95, 2010.

J. Bacchetta and A. , FGF 23 : régulations et fonctions, Pathologie phosphocalcique et osseuse de l'enfant

E. Grethen, K. Hill, R. Jones, B. Cacucci, C. Gupta et al., Serum Leptin, Parathyroid Hormone, 1,25-Dihydroxyvitamin D, Fibroblast Growth Factor 23, Bone Alkaline Phosphatase, and Sclerostin Relationships in Obesity, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.5, pp.1655-62, 2012.
DOI : 10.1210/jc.2011-2280

URL : https://academic.oup.com/jcem/article-pdf/97/5/1655/7925623/jcem1655.pdf

R. Saini, I. Kaneko, P. Jurutka, R. Forster, A. Hsieh et al., 1,25-Dihydroxyvitamin D3 Regulation of Fibroblast Growth Factor-23 Expression in Bone Cells: Evidence for Primary and Secondary Mechanisms Modulated by Leptin and Interleukin-6, Calcified Tissue International, vol.111, issue.4, pp.25-339, 2013.
DOI : 10.1002/jcb.22842

J. Bacchetta, P. Cochat, and I. Salusky, [FGF23 and Klotho: the new cornerstones of phosphate/calcium metabolism]. Arch Pediatr Organe Off Soc Francaise Pediatr, juin, vol.18, issue.6, pp.686-95, 2011.

D. Gkentzi, A. Efthymiadou, D. Kritikou, and D. Chrysis, Fibroblast growth factor 23 and Klotho serum levels in healthy children, Bone, vol.66, pp.8-14, 2014.
DOI : 10.1016/j.bone.2014.05.012

C. Chen, S. Podvin, E. Gillespie, S. Leeman, and C. Abraham, Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17, Proceedings of the National Academy of Sciences, vol.14, issue.7
DOI : 10.1172/JCI26052

M. Kuro-o and . Klotho, Klotho, Pfl??gers Archiv - European Journal of Physiology, vol.36, issue.Pt 1, pp.333-376, 2010.
DOI : 10.1165/ajrcmb.22.1.3554

S. Liu, L. Vierthaler, W. Tang, J. Zhou, and L. Quarles, FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23, Journal of the American Society of Nephrology, vol.19, issue.12, pp.2342-50, 2008.
DOI : 10.1681/ASN.2007121301

M. Razzaque, FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?, American Journal of Physiology-Renal Physiology, vol.296, issue.3, pp.470-476, 2009.
DOI : 10.1210/en.2005-0670

Q. Chang, S. Hoefs, A. Van-der-kemp, C. Topala, R. Bindels et al., The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel, Science. 21 oct, vol.310, issue.5747, pp.490-493, 2005.
DOI : 10.1126/science.1114245

M. Razzaque, . Klotho, and K. Na+, ATPase activity: solving the calcium metabolism dilemma? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, févr, vol.23, issue.2, pp.459-61, 2008.
DOI : 10.1093/ndt/gfm702

URL : https://academic.oup.com/ndt/article-pdf/23/2/459/5241925/gfm702.pdf

H. Tsujikawa, Y. Kurotaki, T. Fujimori, K. Fukuda, Y. Nabeshima et al., , a Gene Related to a Syndrome Resembling Human Premature Aging, Functions in a Negative Regulatory Circuit of Vitamin D Endocrine System, Molecular Endocrinology, vol.17, issue.12, pp.2393-403, 2003.
DOI : 10.1210/me.2003-0048

I. Wolf, D. Stein, S. Shahmoon, S. Ziv, R. Hemi et al., Alteration in serum klotho levels in anorexia nervosa patients, Clinical Nutrition, vol.35, issue.4, pp.958-62, 2016.
DOI : 10.1016/j.clnu.2015.07.013

Y. Yamazaki, A. Imura, I. Urakawa, T. Shimada, J. Murakami et al., Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects, Biochemical and Biophysical Research Communications, vol.398, issue.3, pp.513-521, 2010.
DOI : 10.1016/j.bbrc.2010.06.110

B. Riou and L. Lichtenberger, Impact de la supplémentation eh phosphore sur l'évolution du FGF 23 chez les adolescent(e)s anorexiques, étude préliminaire, 2015.
DOI : 10.1016/j.arcped.2016.09.029

L. Lichtenberger, Impact de la supplémentation en phosphore sur l'évolution à 6 mois du FGF23 chez les adolescent(e)s anorexiques en situation de dénutrition, 2015.

M. Otani, Y. Takimoto, J. Moriya, K. Yoshiuchi, and A. Akabayashi, Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa, BioPsychoSocial Medicine, vol.311, issue.1, p.10, 2008.
DOI : 10.1056/NEJM198412203112503

URL : https://doi.org/10.1186/1751-0759-2-10

M. Otani, Y. Takimoto, J. Moriya, K. Yoshiuchi, and A. Akabayashi, Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study, BioPsychoSocial Medicine, vol.5, issue.1, p.7, 2011.
DOI : 10.1111/j.1365-2265.2007.02824.x

J. Hum, O. Bryan, L. Smith, R. White, and K. , Novel functions of circulating Klotho, Bone, vol.100, 2016.
DOI : 10.1016/j.bone.2016.11.025

M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga et al., Mutation of the mouse klotho gene leads to a syndrome resembling ageing, Nature, vol.390, issue.6655, pp.45-51, 1997.
DOI : 10.1038/36285

M. Hu, M. Shi, J. Zhang, J. Pastor, T. Nakatani et al., Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule, The FASEB Journal, vol.24, issue.9, pp.3438-50, 2010.
DOI : 10.1152/ajprenal.2000.279.5.F841

N. Rigotti, R. Neer, S. Skates, D. Herzog, and S. Nussbaum, The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass, JAMA: The Journal of the American Medical Association, vol.265, issue.9, pp.1133-1141, 1991.
DOI : 10.1001/jama.265.9.1133

L. Robinson, V. Aldridge, E. Clark, M. Misra, and N. Micali, A systematic review and meta-analysis of the association between eating disorders and bone density, Osteoporosis International, vol.51, issue.12, pp.1953-66, 2016.
DOI : 10.1038/sj.ejcn.1600492

E. Ghoch, M. Gatti, D. Calugi, S. Viapiana, O. Bazzani et al., Dalle Grave R. The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review, Nutrients. 29 nov, vol.8, issue.12, 2016.

D. Gatti, E. Ghoch, M. Viapiana, O. Ruocco, A. Chignola et al., Strong relationship between vitamin D status and bone mineral density in anorexia nervosa, Bone, vol.78, pp.212-217, 2015.
DOI : 10.1016/j.bone.2015.05.014

L. Sze, R. Bernays, C. Zwimpfer, P. Wiesli, M. Brändle et al., Excessively high soluble Klotho in patients with acromegaly, Journal of Internal Medicine, vol.18, issue.1, pp.93-100, 2012.
DOI : 10.1016/j.ghir.2008.05.005

I. Wolf, S. Shahmoon, B. Ami, M. Levy-shraga, Y. Mazor-aronovitch et al., Association between Decreased Klotho Blood Levels and Organic Growth Hormone Deficiency in Children with Growth Impairment, PLoS ONE, vol.95, issue.9, p.107174, 2014.
DOI : 10.1371/journal.pone.0107174.t002

T. Rubinek, S. Shahmoon, A. Shabtay-orbach, B. Ami, M. Levy-shraga et al., Klotho response to treatment with growth hormone and the role of IGF-I as a mediator, Metabolism, vol.65, issue.11, pp.1597-604, 2016.
DOI : 10.1016/j.metabol.2016.08.004

K. Tsuji, T. Maeda, T. Kawane, A. Matsunuma, and N. Horiuchi, Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1??,25-dihydroxyvitamin D3 synthesis in leptin-deficient ob/ob Mice, Journal of Bone and Mineral Research, vol.83, issue.8, pp.1711-1734, 2010.
DOI : 10.1172/JCI200419081

D. Lydia and L. , Service de Pédiatrie Médicale et Médecine de l'Adolescent CHU Amiens-Picardie Salouël-80054 Amiens cedex 1

. Dans-le-cadre-de-la-recherche-d, évaluation des soins courants à laquelle le CHU d'Amiens vous propose de participer, un traitement informatique des données personnelles de votre enfant sera mis en oeuvre pour permettre d'analyser les résultats de la recherche. A cette fin, les données médicales concernant votre enfant seront transmises au promoteur de la recherche et aux personnes ou sociétés agissant pour son compte, en France. Ces données seront identifiées par un code et

C. Document, Après avoir lu cette note d'information, n'hésitez pas à poser à votre médecin toutes les questions que vous désirez. Il vous sera possible de poser ces questions à tout moment, avant et en cours d'étude. Il vous est garanti que toute information nouvelle survenant pendant votre participation et pouvant modifier votre décision de participation vous sera donnée